⌘K

Home/Filings/4/0000899243-23-009714

4//SEC Filing

AHMED NADIM 4

Accession 0000899243-23-009714

CIK 0001789972other

View on SEC.gov Company Profile

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 4:05 PM ET

Size

5.0 KB

Accession

0000899243-23-009714

Insider Transaction Report

Form 4

Period: 2023-03-23

Cullinan Oncology, Inc.CGEM

DirectorPresident and CEO

Transactions

Sale
Common Stock
2023-03-23$10.51/sh−706$7,420→ 118,004 total

Footnotes (1)

[F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cullinan Oncology, Inc.

CIK 0001789972

Entity typeother

Related Parties

1

filerCIK 0001731193

Filing Metadata

Form type: 4
Filed: Mar 26, 8:00 PM ET
Accepted: Mar 27, 4:05 PM ET
Size: 5.0 KB

View on SEC.gov